MAP3K14 and cerebrovascular disorder: Hyperlipidemia increases the risk of cardio-cerebrovascular disease in patients with type 2 diabetes, and hyperlipidemia combined with the elevation of hs-CRP may induce higher risk of cardio-cerebrovascular disease in patients with type 2 diabetes.